A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients with life-limiting disease

Overview of attention for article published in Supportive Care in Cancer, February 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,522 followers.

A randomised, double-blind controlled trial of intranasal midazolam for the palliation of dyspnoea in patients wit… https://t.co/VthHyFHye3

RT @agadoud: intranasal midaz no better than placebo for breathlessness https://t.co/SjVxu3NWvp #springerlink

intranasal midaz no better than placebo for breathlessness https://t.co/SjVxu3NWvp #springerlink

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.